Home › Seizures › California › Los Angeles
Seizures clinical trials in Los Angeles, CA
5 studies for Seizures are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
RecruitingPhase 2
- Clinical Research Institute, Los Angeles
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Southern California Keck Hospital, Los Angeles
- University of California Los Angeles, Los Angeles
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- University of California Los Angeles (UCLA), Los Angeles
Pediatric Dose Optimization for Seizures in Emergency Medical Services
RecruitingPhase 3
- Children's Hospital of Los Angeles, Los Angeles
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
- University of Southern California, Los Angeles
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA11 studies
- Houston, TX8 studies
- Boston, MA8 studies
- Birmingham, AL7 studies
- Miami, FL6 studies
- Chicago, IL6 studies
- Dallas, TX6 studies
- Durham, NC6 studies
- Cincinnati, OH6 studies
- Orlando, FL5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.